News | June 03, 2022
GSK to form consumer healthcare business ‘Haleon’
The proposed demerger is the most significant corporate change for GSK in the last 20 years
The proposed demerger is the most significant corporate change for GSK in the last 20 years
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
East Syracuse site to serve as the LOTTE Center for North America Operations for LOTTE’s biologics contract development and manufacturing organization (CDMO) business
The company intends to begin using drones to make deliveries of critical and emergency medical supplies, vaccines, and lifesaving drugs after getting the prerequisite regulatory approvals
Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
Subscribe To Our Newsletter & Stay Updated
